semaglutide weight loss stall Overcome a Plateau: Strategies & Services Weight-loss plateau on Semaglutide :

For tirzepatide at the highest dose, the SURMOUNT-1 trial showed an average of 22.5% weight loss at 72 weeks, which represents one of the most significant weight loss results ever achieved with any medication

Yuneva MO, Fan TWM, Allen TD, Higashi RM, Ferraris DV, Tsukamoto T, et al

Hellerup, February 23, 2026 On behalf of the board of directors Albert Cha Chair Exhibit 99.2 Ascendis Pharma A/S Tuborg Boulevard 12 DK-2900 Hellerup Central Business Registration No

This is not a quality issue

Recently, concerns about suicidal thoughts and behaviours have been raised, after a global analysis reviewed more than 36 million reports of adverse events from semaglutide (Ozempic or Wegovy) since 2000